TPMT Genotype and Adverse Effects of Azathioprine Among Jordanian Group.
Inflammatory Bowel Disease (IBD) is a common disease affecting many patients. This disease is treated by azathioprine and TPMT genetic polymorphism affect the patient's tolerance. The aim of this study is to investigate the importance of TMPT genotyping in reducing the incidence of azathioprine adverse effect. One hundred and forty-one IBD patients were followed for azathioprine Adverse Drug Reaction (ADR). Patients were genotyped for TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C. The frequency of Azathioprine adverse effect was about 35.5%. An association between TPMT genotypes 1/3A and 3B/3B and azathioprine related bone marrow suppression was found (P value ≤ 0.05). The findings suggest that there was significant association between TPMT genotypes 1/3A and 3B/3B and azathioprine related bone marrow suppression.